METABOLIC EFFECTS OF ASTROLIN (INULIN-BASED DRUG) IN PATIENTSWITH DIABETES MELLITUS TYPE 2
- Authors: Bakumov PA1, Kozyrenko Y.V1, Bakumov PA1, Kozyrenko Y.V1
-
Affiliations:
- Issue: Vol 5, No 4 (2008)
- Pages: 17-18
- Section: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/118002
- ID: 118002
Cite item
Full Text
Abstract
An investigation of the effect of the inulin-containing medication (Astrolin) on carbohydrate and lipid metabolism in complex
therapy of patients with diabetes mellitus type 2 was conducted. When added to the basic therapy of diabetes type 2 it contributed
to decrease of glucose blood level by 15 %, glycosylated haemoglobin by 10 %, total cholesterol by 13 %, beta-lipoproteids by 12 % and triglycerides by 22 %. A good tolerance of the medication was demonstrated in the study. Astrolin is recommended in the complex therapy of patients with diabetes mellitus type 2.
therapy of patients with diabetes mellitus type 2 was conducted. When added to the basic therapy of diabetes type 2 it contributed
to decrease of glucose blood level by 15 %, glycosylated haemoglobin by 10 %, total cholesterol by 13 %, beta-lipoproteids by 12 % and triglycerides by 22 %. A good tolerance of the medication was demonstrated in the study. Astrolin is recommended in the complex therapy of patients with diabetes mellitus type 2.
References
- Балаболкин М. И. Диабетология. - М. Медицина, 2000.
- Дедов И. И., Чазова Т. Е., Сунцов Ю. И. Эпидемиология сахарного диабета. - М., 2003.
- Павлюк П. М. Состояние углеводного и липидного обмена у больных сахарным диабетом 2 типа, принимавших «Инулин-Нутримед». - Киев: Семейная медицина, 2005.
Supplementary files
